Member Info for BuenaVista

Wyndrum has always posted in bad faith. Wyndrum is not a serious poster. Should be green boxed, or posts ignored and reported.

Nov 12, 2018

"President-elect Trump hosted the chief executives of Pfizer, Eli Lilly and PhRMA Wednesday night at Mar-a-Lago, where they discussed how the public and private sectors can collaborate on finding cures for cancer, among other topics, Axios has learned.

"Why it matters: The patio dinner is a potential indication that Trump's administration will see the pharmaceutical industry as a partner — not just an adversary — for parts of its "Make America Healthy Again" agenda."

https://www.axios.com/2024/12/05/trump-rfk-jr-pfizer-lilly

Please do not feed the trolls...

@Bella, I'm pretty sure all patients remaining in Phase 1a will continue to be dosed until they can no longer be dosed, and that those still alive will be monitored for a year or more or until they enroll on a different trial.

Still not awake yet... 'dosing regimen', not 'RDE'.

Apologies LLP, I misread. But I think you meant the RDE is approved.

What's the dosing regimen LLP? I've not seen anything about it.

The development process takes as long as it takes. The problem delay is in not getting any revenue in from DX sale, licensing, partnering etc.

P1a still ongoing in that they continue to dose those patients that are responding. Is that a bad thing General?

Nothing except the little matter of Avacta continuing as a going concern come audit time.

In terms CC would understand, that RNS was a nothingburger.

Yes LL, that could well be it. I'm supposing that the RDE (with frequency of dosing) is a trade secret and not omitted because CC has disregard for the audience.

Agreed lor_9.

They clearly haven't got a rich farmer on the hook yet for TNBC.

What is this? Have they done another Phase 1a cohort with the dosing regimen they (Avacta in consultation with the FDA) were putting forward as the regimen for Phase 1b?

CC needs to know she's communicating to a British retail investor and trader community, not a NASDAQ audience.

That's a VERY unsatisfactory RNS. Tells nothing we didn't already know except that they are now finally about ready to start to enroll patients in Phase 1b.

BBB, I see a list of the biopharma RNS and Reach announcements every morning that the market is open and it is far from normal to get cohort or even trial phase updates (except for interim results). Having said that, it would have been / would be good to get confirmation that Phase 1b has actually started rather than vague references about it, as was also the case with Phase 1a completing.

100%. MM is not your friend. CC is not your friend. Be suspicious of everyone. Trust no one. Lock your door. Look under your bed. They're everywhere!

Makes sense!

V-S, how do you know/why do you think it was a worked sell?